Form 4 for XYL Xylem Inc.
Accepted 2023-11-16 00:00:00 ET · period of report 2023-11-14 · accession 0001562180-23-007729 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2023-11-16 | 2023-11-14 | XYL | Decker Patrick | Pres, CEO, Dir | M - OptEx | $35.96 | +99.6K | 387.2K | +35% | +$3.58M |
| DMT | 2023-11-16 | 2023-11-14 | XYL | Decker Patrick | Pres, CEO, Dir | S - Sale+OE | $100.85 | -99.6K | 287.6K | -26% | -$10.05M |
| DT | 2023-11-16 | 2023-11-14 | XYL | Decker Patrick | Pres, CEO, Dir | M - OptEx | $0.00 | -99.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-14 | M | A | 99,648 | $35.96 | 387,212 | D | — | — | |
| 2 | Common | Common Stock | 2023-11-14 | S | D | 50,458 | $100.57 | 336,754 | D | — | — | (F1) The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2023. (F2) This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $100.04 to $101.035. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
| 3 | Common | Common Stock | 2023-11-14 | S | D | 49,190 | $101.13 | 287,564 | D | — | — | (F1) The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2023. (F3) This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $101.04 to $101.30. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
| 4 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2023-11-14 | M | D | 99,648 | $0.00 | 0 | D | $35.96 · — to 2025-02-24 | 99,648 Common Stock | (F4) The February 24, 2015 option grant vested one-third on February 24, 2016, February 24, 2017 and February 24, 2018. |